Gladius Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$5.05M |
| 2 |
Apple
AAPL
|
+$3.96M |
| 3 |
Eli Lilly
LLY
|
+$3.24M |
| 4 |
Tesla
TSLA
|
+$3.11M |
| 5 |
Amazon
AMZN
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.13M |
| 2 |
Cardinal Health
CAH
|
+$1.11M |
| 3 |
Manhattan Associates
MANH
|
+$1.1M |
| 4 |
Caterpillar
CAT
|
+$1.09M |
| 5 |
VeriSign
VRSN
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.56% |
| 2 | Consumer Discretionary | 2.77% |
| 3 | Communication Services | 2.65% |
| 4 | Financials | 1.76% |
| 5 | Healthcare | 1.38% |
Similar funds
Gladius Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Gladius Capital Management held 280 positions worth $932M, up 12% from $830M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Gladius Capital Management deployed $70.6M of net new capital in Q4 2024, opening 3 new positions and adding to 29 existing holdings. Its largest new stake was Morgan Stanley: 9,482 shares worth $1.19M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 9.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $530K trimmed.
- Gladius Capital Management's largest Q4 2024 buy was Morgan Stanley: 9,482 shares worth $1.19M.
- Gladius Capital Management added most to Alphabet (Google) Class C in Q4 2024, an estimated $5.05M increase.
- Gladius Capital Management's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $530K.
- Gladius Capital Management fully exited CVS Health in Q4 2024, selling an estimated $1.13M.
- Gladius Capital Management's ten largest holdings make up 59% of its $932M portfolio in Q4 2024.
- Gladius Capital Management opened 3 new positions and closed 207 in Q4 2024.
- Gladius Capital Management's portfolio value rose 12% quarter-over-quarter to $932M.
Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.